4//SEC Filing
BIOSITE INC 4
Accession 0001238918-07-000003
CIK 0000834306operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 12:46 PM ET
Size
13.2 KB
Accession
0001238918-07-000003
Insider Transaction Report
Form 4
BIOSITE INCBSTE
DEMARIA ANTHONY
Director
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−4,062→ 0 totalExercise: $45.02Exp: 2016-11-01→ Common Stock (4,062 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−92→ 0 totalExercise: $47.66Exp: 2013-06-18→ Common Stock (92 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−2,820→ 0 totalExercise: $53.38Exp: 2015-06-17→ Common Stock (2,820 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−1,345→ 0 totalExercise: $44.18Exp: 2014-06-18→ Common Stock (1,345 underlying)
Footnotes (4)
- [F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 2,409 shares of Inverness common stock for $24.66 per share.
- [F2]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 7,277 shares of Inverness common stock for $25.13 per share.
- [F3]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 164 shares of Inverness common stock for $26.61 per share.
- [F4]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 5,052 shares of Inverness common stock for $29.80 per share.
Documents
Issuer
BIOSITE INC
CIK 0000834306
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000834306
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 12:46 PM ET
- Size
- 13.2 KB